Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Operating Expenses (2016 - 2025)

Bio-Techne (TECH) has 17 years of Operating Expenses data on record, last reported at $136.8 million in Q4 2025.

  • For Q4 2025, Operating Expenses fell 6.59% year-over-year to $136.8 million; the TTM value through Dec 2025 reached $675.8 million, up 15.59%, while the annual FY2025 figure was $688.0 million, 22.2% up from the prior year.
  • Operating Expenses reached $136.8 million in Q4 2025 per TECH's latest filing, down from $140.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $222.7 million in Q2 2025 and bottomed at $99.6 million in Q1 2021.
  • Average Operating Expenses over 5 years is $133.3 million, with a median of $126.3 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: surged 45.07% in 2021, then decreased 8.02% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $121.3 million in 2021, then fell by 4.84% to $115.5 million in 2022, then increased by 20.02% to $138.6 million in 2023, then grew by 5.69% to $146.5 million in 2024, then dropped by 6.59% to $136.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $136.8 million in Q4 2025, $140.5 million in Q3 2025, and $222.7 million in Q2 2025.